COVID-19 Pills May Conflict With , Certain Medications, Study Finds.
NBC News reports experts are warning anti-viral pills created by Pfizer and Merck may not be safe for everyone.
Recently cleared by the Food and Drug Administration to treat infections in patients 12 and older, anti-viral pills have been a cause for optimism in the fight against COVID-19.
According to NBC News, experts have found that certain ingredients in the anti-viral pills
may cause extreme reactions when paired with more widely-used medications.
Oddly enough, many of the affected medications are widely prescribed to those with the highest risk of developing COVID-19 complications.
Oddly enough, many of the affected medications are widely prescribed to those with the highest risk of developing COVID-19 complications.
These medications include antidepressants, immunosuppressants and even inhalers.
These medications include antidepressants, immunosuppressants and even inhalers.
Some of these potential interactions are not trivial,
and some pairings have to be avoided altogether. , Peter Anderson, professor of pharmaceutical science,
University of Colorado, via NBC News.
Some of these potential interactions are not trivial,
and some pairings have to be avoided altogether. , Peter Anderson, professor of pharmaceutical science,
University of Colorado, via NBC News.
Some are probably easily managed. But some we’re
going to have to be
very careful about. , Peter Anderson, professor of pharmaceutical science,
University of Colorado, via NBC News.
Some are probably easily managed. But some we’re
going to have to be
very careful about. , Peter Anderson, professor of pharmaceutical science,
University of Colorado, via NBC News.
Amid concerns, experts remain excited
by the potential of anti-viral pills.
This could make a real difference in the pandemic by making an effective Covid treatment
available to many people. , Peter Anderson, professor of pharmaceutical science,
University of Colorado, via NBC News.
This could make a real difference in the pandemic by making an effective Covid treatment
available to many people. , Peter Anderson, professor of pharmaceutical science,
University of Colorado, via NBC News